XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Retained earnings
Accumulated other comprehensive income (loss)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2022   18,730,380    
Beginning balance at Dec. 31, 2022 $ 562,147 $ 226,592 $ 435,085 $ (99,530)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 5,058   5,058  
Share-based compensation expense 1,016 $ 1,016    
Common stock issued - Stock grants (in shares)   50,426    
Common stock issued - Stock grants 0      
Other comprehensive income 13,772     13,772
Dividends declared on common stock (6,684)   (6,684)  
Common stock repurchased (in shares)   (12,995)    
Common stock repurchased (315) $ (315)    
Common stock shares outstanding, ending balance (in shares) at Mar. 31, 2023   18,767,811    
Ending balance at Mar. 31, 2023 $ 574,994 $ 227,293 433,459 (85,758)
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2023 18,810,055 18,810,055    
Beginning balance at Dec. 31, 2023 $ 538,387 $ 229,889 395,357 (86,859)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (7,497)   (7,497)  
Share-based compensation expense 1,059 $ 1,059    
Common stock issued - Stock grants (in shares)   60,483    
Common stock issued - Stock grants 0      
Other comprehensive income (4,482)     (4,482)
Common stock repurchased (in shares)   (12,972)    
Common stock repurchased $ (134) $ (134)    
Common stock shares outstanding, ending balance (in shares) at Mar. 31, 2024 18,857,566 18,857,566    
Ending balance at Mar. 31, 2024 $ 527,333 $ 230,814 $ 387,860 $ (91,341)